Life Spot Capital AG will be the first E-Health
Technology and solutions in the stock market
DGAP-News: Life Spot Capital AG / Key word (s):
Participation / Unternehmensbeteiligung / Change of Personnel Life Spot Capital AG
presents itself as the first e-Health technology and
Solution providers in the stock market
30.06.2015 / 08:05
Press release the Life Spot Capital AG
Life Spot Capital AG presents itself as the first e- Health
Technology and solutions in the stock market
– focus on telemedicine solutions and Medical Big Data
– With BodyTel GmbH and Life Spot AG two innovative investments in
Portfolio
Other planned takeovers of established e-health company
Hamburg / Munich, 30.06.2015 – –
which is listed on the Hamburg Stock Exchange
former NBIC Capital AG (ISIN DE000A0DNBJ4) has, as in the
Announced shareholders’ meeting on 30.12.2014, a new strategic
aligned. Immediately it presents itself under the name
Life Spot Capital AG, with new Executive Board members, and two new
Investments from the promising e-health market at the
Market.
The Life Spot Capital AG develops solutions for digitizing the
Health and the realization of interoperability, the
Exchange of information of different systems and techniques
medical field, at home and abroad. The focus is in front
due to the improvement of patient care and the creation of
a reliable, secure and standardized
Communication structure between patients and providers of
Health Services placed. In addition, will the
Society functions of the booming wearables as
Fitness bands and Smart Watches, with a medical monitoring,
the combined connected with an app and database
important preventive added value for patients, physicians and
Pension provider offers, complete.
Currently has the Life Spot Capital AG two owns 100% subsidiaries
in the portfolio. The BodyTel GmbH is a for several years on the market
established German manufacturer and provider of telemedical
Total solutions with permanent establishment in Bad Wildungen. The Company
has specialized in the development of innovative, medical
Communication platforms and devices, for example, to monitor
chronic diseases, specialized. The dermatological
Application of Life Spot AG developed an expert system,
which offers the possibility of a reliable First Opinion
obtain a dermatological disease. Here outbids the
Companies among other doctors the possibility already
to pledge or detailed diagnosed diseases
Retrieve information to document diseases and their
To monitor progress. Based on a neuronal image and
Pattern Recognition software provides a dermatological application
Unique selling point, which in the future to other
Medical conditions and indications can be transferred.
As part of a buy-and-build strategy is the Life Spot Capital AG
through the acquisition of well-established e-health company to
powerful group in a highly attractive and fast-growing
Future market be extended.
“Our goal is that Life Spot Group as a long-term
to establish profitable technology companies and unique
Synergy and cross-selling potential to lift, “explains Dr. Harald
Dörsch, CEO of Life Spot Capital AG. The
experienced managers has extensive international
Expertise in the fields of medical technology, IT, pharmaceuticals and life
Science and can on a stable, international network
recourse. Dr. Dörsch has for well-known companies such as
DaimlerChrysler Aerospace, Siemens, B2X, Bosch, B.Braun Aesculap and
worked. Beside him Sabrina Müller was appointed to the Board. In
With its many years as Head Marketing, Investor and
Public Relations a listed investment company,
responsible for them in addition to the capital market communication and
Positioning In addition, the Life Science portfolio with the
Focus E-Health.
Following the realignment is a relocation of the company headquarters
to Munich and the listing in the continuous trading
Munich Stock Exchange planned
About the Life Spot Capital AG:.
The Life Spot Capital AG is a technology and solutions provider in the
Growth field eHealth and is a full service
Telemedicine specialist. For this, the Life Spot Capital AG bundles its
Technologies and solutions in operational units or
Subsidiaries that focus on telemedicine solutions
Medical and Big Data are specialized and takes the role
the parent company of this one e-health network. Based
a solid organic growth involved the Life Spot
Capital AG as part of a buy-and-build strategy through
established majority takeovers of already on the market
EHealth companies. The company pursues the goal of the
Life Spot Group to a profitable long term
Technology company in an attractive market segment
expand. Currently listed the shares on the Hamburg Stock Exchange under
the ticker symbol CDZ, ISIN: DE000A0DNBJ4
Contact Life Spot Capital AG: Sabrina Müller Public & amp;. Investor
Relations Denisstr. 1b D-80335 München Tel: +49 – 89-244-192-200
Fax: +49 – 89-244-192-230 sabrina.mueller (at) lifespotcapital.com
www.lifespotcapital.com
ISIN: DE000A0DNBJ4 | WKN: A0DNBJ | Symbol: CDZ
30.06.2015 Dissemination of a Corporate News / financial news
transmitted by DGAP – a service of EQS Group AG. For the
Content of this announcement is the issuer / publisher responsible.
DGAP’s Distribution Services include Regulatory Announcements,
Financial / Corporate News and Press Releases.
Media archive at and http://www.dgap-medientreff.de
http://www.dgap.de
373 261 30.06.2015
ISIN DE000A0DNBJ4
AXC0043 2015-06-30 / 08: 05
No comments:
Post a Comment